Shafique Virani, Chief Business Officer at RECURSION PHARMACEUTICALS, INC. (RXRX), sold 21,603 shares at $6.51 ($143K) on 2023-11-15, disclosed to the SEC on 2023-11-17.
Scheduled sale ($143k) by Chief Business Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.51 | 18,000 | $117K | 81.9% |
| 2 | $7.18 | 3,603 | $26K | 18.1% |
| Total | $6.62 avg | 21,603 | $143K | 100% |
| Filing → |
| RXRX | SELL | 2023-10-18 | $113K | — | Filing → |
| RXRX | SELL | 2023-09-19 | $156K | — | Filing → |
| RXRX | SELL | 2023-08-17 | $167K | — | Filing → |